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What Is Causing Active Trachoma? The Role of
Nonchlamydial Bacterial Pathogens in a Low
Prevalence Setting
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Caroline Chevallier,4 Isaac A. Afwamba,4 Paul Courtright,2 Helen A. Weiss,5
David C. W. Mabey,1 and Robin L. Bailey1
PURPOSE. In low prevalence settings, clinically active follicular
trachoma (TF) is often found in the absence of detectable Chla-
mydia trachomatis. The reasons for this persistent follicular phe-
notype are not well understood; one possible explanation is that
other bacterial species are provoking the inflammatory response.
This study investigated the relationship between TF, C. tracho-
matis, and nonchlamydial bacterial infection.
METHODS. A cross-sectional survey was conducted in a trachoma
endemic village in Tanzania. All available children were examined
for trachoma and swabs were collected for microbiologic culture
(blood and chocolate agar) and C. trachomatis PCR (Amplicor).
RESULTS. Four hundred seventy-three children under 10 years of
age were recruited for this study. The prevalences of TF and C.
trachomatis were 13.7% and 5.3%, respectively, and were not
associated. Bacteria were cultured from 305 (64.5%) swab sam-
ples; 162 (34.3%) grew a pathogen (with or without a commensal
organism) and 143 (30.2%) grew commensal bacteria only. The
most common pathogens were Streptococcus pneumoniae and
Haemophilus influenzae (type B and non–type B). The presence
of bacterial pathogens was associated with TF (odds ratio, 4.68;
95% confidence interval, 2.31–9.50; P  0.001).
CONCLUSIONS. In regions with low levels of endemic trachoma, it
is possible that much of the TF that is observed is attributable to
nonchlamydial bacterial pathogens. It is plausible that individuals
who have previously developed a follicular conjunctivitis in re-
sponse to C. trachomatis may more readily reform conjunctival
follicleswhen challengedwith certain other bacterial species. (Invest
Ophthalmol Vis Sci. 2011;52:6012–6017)DOI:10.1167/iovs.11-7326
Trachoma remains a leading cause of blindness in many ofthe world’s poorest regions.1 It is caused by the obligate
intracellular bacterium Chlamydia trachomatis, and is charac-
terized by episodes of recurrent, chronic follicular conjuncti-
vitis. In some individuals, this inflammation results in progres-
sive scarring of the tarsal conjunctiva, leading to the blinding
complications of trichiasis and corneal opacification.
The control of blinding trachoma focuses on the implemen-
tation of the surgery, antibiotics, facial cleanliness, and envi-
ronmental improvement (SAFE) strategy.2 Current World
Health Organization (WHO) guidelines recommend annual
mass drug administration (MDA) with oral azithromycin or
topical tetracycline for 3 years to entire communities where
the prevalence of trachomatous inflammation–follicular (TF;
Simplified WHO Trachoma Grading System3) in children 1 to 9
years of age (TF%1–9) is greater than 10%.
2 However, it has been
recognized for some time that in low prevalence settings, the
relationship between the signs of TF and the detection of C.
trachomatis infection is variable and at times very weak.4–7
This relationship becomes even less consistent after the intro-
duction of antibiotic control programs.8–10
The discordance between disease and chlamydial infection
is an increasingly important issue for trachoma control pro-
grams as the prevalence of trachoma declines. When deciding
to initiate or stop MDA, programs currently have no practical
alternative to assessing the prevalence of clinical signs of active
trachoma. There are probably several factors that contribute to
the mismatch in signs and infection. First, the temporal se-
quence for these two events differs: infection probably starts
and finishes before the inflammatory response, which can
persist for many weeks after the resolution of infection.11 At a
population level, the prevalence of TF appears to take very
much longer to decline after the initiation of MDA than the
prevalence of chlamydial infection.8–10 It has been found to
stay above the 10% TF treatment threshold for months or years
in the absence of detectable chlamydial infection. Second,
there are other recognized causes of a follicular conjunctivitis,
such as other bacteria and certain viruses. It is plausible that, in
an individual who has previously developed a follicular re-
sponse to C. trachomatis, subsequent nonchlamydial infec-
tions causing conjunctival inflammation might be more likely
to elicit a follicular reaction that mimics TF.
To investigate the relationship between the signs of TF and
C. trachomatis and other bacterial species, we conducted a
cross-sectional survey of the children living in a trachoma-
endemic community, relating the clinical phenotype to labo-
ratory evidence of infection.
METHODS
Ethical Approval
This study adhered to the tenets of the Declaration of Helsinki. It was
approved by the Tanzanian National Institute of Medical Research
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Ethics Committee, the Kilimanjaro Christian Medical Centre Ethics
Committee, and the London School of Hygiene and Tropical Medicine
Ethics Committee. The study was explained to the parents/guardians
of potential study subjects. Informed consent was documented in
writing by the parent/guardian on behalf of each child before recruit-
ment.
Study Participants
The study was conducted in a single village in Siha District, Kilimanjaro
Region, Northern Tanzania. We carried out a census of the village. All
children under 10 years of age who were present and for whom
consent was given were enrolled into the study. This district had never
received MDA for trachoma control.
Clinical Assessment and Sample Collection
The left eye of each subject was examined by a single ophthalmologist
(MJB) using 2.5 loupes and a bright torch. Clinical signs were graded
using the 1981 WHO Trachoma Grading System (FPC).12 Clinically
active trachoma was defined as the presence of either a follicular score
of 2 or 3 (F2/3) or a papillary score of 3 (P3), equivalent to TF and
trachomatous inflammation–intense (TI) of the WHO Simplified Tra-
choma Grading System, respectively.3 The conjunctiva was anesthe-
tized with preservative-free proxymetacaine 0.5% eye drops (Minims;
Chauvin Pharmaceuticals, Surrey, UK). A rayon-tipped swab sample
was collected from the inferior fornix, placed immediately into Amies–
charcoal transport media (Sterilin, Caerphilly, UK) and kept at ambient
temperature until processing in the laboratory later the same day. A
second, Dacron polyester–tipped swab (Hardwood Products Com-
pany, Guilford, Maine) was collected from the left upper tarsal con-
junctiva for the detection of C. trachomatis in a standardized manner
(passed firmly four times across the conjunctiva with a quarter turn
between each pass). The samples for PCR were kept on ice packs until
transfer to a –80°C freezer later the same day for storage until process-
ing. The examiner changed gloves before examining and collecting
swabs from each child. “Negative field controls” were collected after
every 50 subjects by passing the swab through the air a few centime-
ters in front of a seated study subject. The village was mass treated with
single dose oral azithromycin immediately after the survey.
Laboratory Tests
Microbiology testing was performed at the KCMC Biotechnology Lab-
oratory, Moshi, Tanzania. Microbiology samples were inoculated onto
blood and chocolate agar later the same day (usually6 hours from the
collection time) and incubated at 37°C for 48 hours. Culture isolates
were identified by standard microbiologic techniques. Testing for C.
trachomatis by PCR was performed at the MRC Laboratories, Gambia;
samples were transferred there on dry ice. DNA was extracted from
the dry swab using an isolation kit (QIAmp DNA mini kit; Qiagen,
Crawley, UK). C. trachomatis was detected using a test kit (Amplicor
CT/NG kit; Roche Molecular Systems, Branchburg, NJ), with previously
described modifications.5,13
Data Analysis
Data were entered into a database (Access 2007; Microsoft, Redmond,
WA) and analyzed using software (STATA, v 11.0; StataCorp LP, Col-
lege Station, TX). A nonparametric test for trend was used to examine
the relationship between bacterial culture results and the ordered
categories of follicular and papillary inflammation severity. 2 tests
were used to determine strength of association for individual bacterial
isolates with the TF status, with an exact test used if there were fewer
than five expected events in a cell. Odds ratios (ORs) and 95% confi-
dence intervals (CIs) for the univariate associations between TF and
each factor were estimated using logistic regression, and P values were
estimated using likelihood ratio tests. Factors associated with TF (P 
0.10) were included in a multivariable logistic regression model. Age
was considered an a priori confounder because of the known associ-
ation with TF. Staphylococcus epidermidis, Corynebacterium spp.,
viridans group streptococci, and Bacillus spp. were designated as
commensal organisms for the purposes of this analysis.
RESULTS
Study Participants and Samples
A total of 700 children under 10 years of age were recorded as
living in the study village at the time of this survey. We were
able to examine 571 (81.5%) children. Of the 129 children not
examined, 58 (45%) had traveled away, 29 (23%) refused, 25
(19%) were too young, and 17 (2%) were not found despite
several visits. Bacteriology and C. trachomatis PCR samples
were collected from 484 (84.8%) and 557 (97.5%) of the 571
children who were examined, respectively. Both bacteriology
and C. trachomatis PCR results were available on a total of 473
of 571 (82.8%) children. Comparing the 473 children for
whom results were obtained and all the other 227 children
living in the village, there was no difference in either the mean
age (P 0.92) or the proportion who were of male sex (47.6%;
P  0.20). The 98 children who were examined but did not
have both microbiology and chlamydial PCR results were
slightly older (5.8 vs. 5.0 years; P  0.01); the proportion that
was male was comparable (P  0.13). All subsequent analyses
are limited to the 473 children with both laboratory results.
Clinical Signs and C. trachomatis Infection
TF was diagnosed in 65 (13.7%) children. The frequencies of
the FPC Grading System follicular (F) and papillary (P) inflam-
mation scores are shown in Table 1. C. trachomatis DNA was
detected by Amplicor PCR in 25 (5.3%) samples. The frequency
of PCR positive samples by clinical grade is shown in Table 1.
There was no association between the presence of TF and the
detection of C. trachomatis (OR, 1.21; 95% CI, 0.40–3.64; P 
0.74). All “negative field controls” tested negative by Amplicor
C. trachomatis PCR.
Conjunctival Bacterial Culture
Bacteria were cultured and identified from 305 (64.5%) swab
samples, of which 162 (34.3%) grew a pathogen (with or
without a commensal organism) and 143 (30.2%) grew com-
mensal bacteria only. A wide range of organisms was cultured
(Table 2). Double infections were found in 107 and triple
infection in 20 eyes. Only 11 of these involved combinations of
TABLE 1. Clinical Disease and C. trachomatis Infection
Follicular Inflammation Papillary Inflammation
n (%)
Infected
(%)* n (%)
Infected
(%)*
FPC score FPC score
F0 323 (68.3) 13 (4.0) P0 372 (78.6) 16 (4.3)
F1 85 (18.0) 8 (9.4) P1 69 (14.6) 5 (7.3)
F2 35 (7.4) 2 (5.7) P2 26 (5.5) 4 (15.4)
F3 30 (6.3) 2 (6.7) P3 6 (1.3) 0 (0.0)
TF TI
No 408 (86.3) 21 (5.1) No 467 (98.7) 25 (5.4)
Yes 65 (13.7) 4 (6.1) Yes 6 (1.3) 0 (0.0)
The frequency of C. trachomatis infection for the different follic-
ular (F) and papillary (P) inflammation grades of the FPC system and
for the trachomatous inflammation—follicular (TF) and trachomatous
inflammation—intense (TI) scores of the Simplified World Health Or-
ganization system.
* This percentage value is for the number infected within each
clinical disease grade.
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the more common pathogenic organisms. There was no signif-
icant difference between the three bacterial infection catego-
ries (no growth, commensal only, and pathogen) in the pro-
portion of eyes with C. trachomatis detected (P  0.21).
Clinical Signs and Bacterial Infection
Pathogenic bacteria were grown from samples from 61.1% of
eyes with TF compared to 29.9% of eyes without TF. There was
no difference in the proportion of eyes with or without TF that
had commensal bacteria (Table 2). Streptococcus pneu-
moniae, Haemophilus influenzae type B, and Haemophilus
influenzae non–type B were significantly more frequent in
eyes with TF (Table 2). There was an increasing trend in the
proportion of eyes with bacterial pathogens cultured with
increasing FPC follicular score (P  0.001; Table 3). There was
a similar but less marked increase for FPC papillary inflamma-
tion (Table 3). There were also significant univariate associa-
tions between TF and being younger than 3 years of age and
with having pathogenic bacteria cultured (Table 4). In a mul-
tivariable logistic regression model, S. pneumoniae, H. influ-
enzae type B, and H. influenzae non–type B were all indepen-
dently associated with TF (Table 5).
DISCUSSION
In this study, the prevalence of TF%1–9 was relatively low
(13.7%) but was still above the 10% treatment threshold for
initiating community level MDA.2 An additional 18% of the
children in this population had a mild follicular conjunctivitis
(FPC grade F1). The prevalence of C. trachomatis detected by
Amplicor PCR was lower (5.3%) than the prevalence of TF.
Overall, we found no association between the signs of active
trachoma and chlamydial infection in this community. These
observations are consistent with findings from other low prev-
alence settings and illustrate the difficulty control programs
face in determining where to invest resources to distribute
antibiotic for trachoma control.6–9 The weak relationship be-
tween the signs of active trachoma and C. trachomatis infec-
tion is likely to lead to many communities receiving unneces-
sary antibiotic treatment. In regions with an initially higher
TABLE 2. Bacteria Cultured from Conjunctival Swabs
Name
All Eyes
(n  473)
No TF
(n  408)
TF
(n  65)
P*n (%) n (%) n (%)
Commensal organisms
Viridans group streptococcus 153 (32.4) 131 (32.1) 22 (33.9) 0.78
Staphylococcus epidermidis 70 (14.8) 61 (14.9) 9 (13.8) 0.82
Corynebacterium spp. 45 (9.5) 40 (9.8) 5 (7.7) 0.59
Bacillus spp. 8 (1.7) 8 (2.0) 0 (0.0) 0.26
Pathogenic organisms
Streptococcus pneumoniae 48 (10.2) 34 (8.3) 14 (21.5) 0.001
Haemophilus influenzae, type B 66 (14.0) 50 (12.6) 16 (24.6) 0.008
Haemophilus influenzae, non–type B 43 (9.1) 28 (6.9) 15 (23.1) 0.001
Micrococcus spp. 8 (1.7) 8 (2.0) 0 (0.0) 0.30
Moraxella catarrhalis 3 (0.6) 3 (0.7) 0 (0.0) 1.00
Haemophilus parainfluenza 2 (0.4) 2 (0.5) 0 (0.0) 1.00
Branhamella catarrhalis 2 (0.4) 2 (0.5) 0 (0.0) 1.00
Neisseria spp. 1 (0.2) 1 (0.3) 0 (0.0) 1.00
Enterobacter spp. 1 (0.2) 1 (0.3) 0 (0.0) 1.00
Klebsiella spp. 1 (0.2) 1 (0.3) 0 (0.0) 1.00
Frequency of bacterial species cultured in all eyes and by presence or absence of trachomatous
inflammation—follicular (TF).
* P values are for 2, comparing the no TF with the TF group. The Fisher’s exact test was used when
there were fewer than five events in a cell.
TABLE 3. Clinical Signs of Trachoma and Type of Conjunctival Bacterial Isolates
Follicular Inflammation Papillary Inflammation
No Growth Commensal Pathogen No Growth Commensal Pathogen
n (%) n (%) n (%) n (%) n (%) n (%)
FPC score FPC score
F0 130 (40.3) 99 (30.7) 94 (29.1) P0 145 (39.0) 114 (30.7) 113 (30.4)
F1 27 (31.8) 30 (35.3) 28 (32.9) P1 16 (23.2) 21 (30.4) 32 (46.4)
F2 6 (17.1) 7 (20.0) 22 (62.9) P2 6 (23.1) 6 (23.1) 14 (53.9)
F3 5 (16.7) 7 (23.3) 18 (60.0) P3 1 (16.7) 2 (33.3) 3 (50.0)
TF TI
No 157 (38.5) 129 (31.6) 122 (29.9) No 167 (35.8) 141 (30.2) 159 (34.0)
Yes 11 (17.0) 14 (21.5) 40 (61.5) Yes 1 (16.7) 2 (33.3) 3 (50.0)
The frequency of bacterial infection for the different follicular (F) and papillary (P) inflammation grades of the FPC System and for the TF and
TI scores of the Simplified WHO system. TF, trachomatous inflammation—follicular; TI, trachomatous inflammation—intense.
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prevalence of disease and chlamydial infection, the relation-
ship between the two weakens markedly after the initiation of
MDA.10
To develop rational strategies for managing MDA in low and
medium prevalence settings, it is necessary to have a better
understanding of the causes of follicular conjunctivitis in tra-
choma endemic communities. Probably part of the explanation
for the discordance between episodes of active disease and C.
trachomatis infection is their different time course.11,14 Folli-
cles in children can persist for weeks or months after the
chlamydial infection is no longer detectable. In low prevalence
settings, C. trachomatis infection prevalence is often so low
that it is difficult to imagine that this alone is sufficient to
sustain a prevalence of TF above the treatment threshold, and
other factors may contribute.7
In this population-based survey, we examined the potential
contribution of nonchlamydial bacterial species to the pres-
ence of a “TF” phenotype. In contrast to C. trachomatis,
nonchlamydial bacteria were frequently cultured from the con-
junctiva of children. The range of organisms included some
that are generally considered commensal and others normally
considered to be pathogens. We found no association between
the presence of TF and the presence of a commensal organism
alone. However, we did find a clear association between TF
and pathogenic bacteria, specifically S. pneumoniae and H.
influenzae. There was no significant difference in the fre-
quency of bacterial pathogens between individuals with no
follicles (F0) and those with very few follicles, below the
diagnostic threshold for TF (F1).
There are little published data on the normal conjunctival
bacterial flora in children in Africa. The only recent study
comes from a village in Sierra Leone, a country that does not
have endemic trachoma, which tested people of all ages.15
This study found 86% had positive cultures (S. epidermidis
28%, S. aureus 20%, P. aeruginosa 6%, Klebsiella 4%, and H.
influenzae 2%). However, there were a number of differences
in the range and relative frequencies of organisms cultured in
these two studies. For example, the study from West Africa did
not identify any S. pneumoniae and only relatively few H.
influenzae. These differences could be attributable to differ-
ences in sample collection and processing (performed in the
United States), population demographics (only 16% under 18
years of age), and the environment (more humid) in the Sierra
Leonean study.
A number of studies have investigated bacterial infection in
children living in trachoma-endemic regions (Table 6).16–21
However, these were mostly conducted before the develop-
ment of sensitive PCR-based techniques for C. trachomatis
detection and the current trachoma grading systems.3,12 In
addition, a number of methodologic variations make it difficult
to draw definite conclusions about the contribution of other
bacteria to follicular conjunctivitis in trachoma-endemic envi-
ronments. Several studies were not population-based, only
including cases with active trachoma or with a limited selec-
tion of unaffected individuals.16,17,20 Two studies present mi-
crobiology results based on microscopy alone (no culture per-
formed).18,20 In these earlier studies, the range of organisms
identified by culture was generally similar to those we found,
albeit with some differences in the relative frequency. In the
most methodologically comparable studies to ours, S. pneu-
moniae and H. influenzae were prominent among the patho-
gens.16,19,21 In two studies, it is possible to partially evaluate
the relationship between active trachoma and bacterial infec-
tion.16,17 In the larger of these, reanalysis of the available data
suggests a significant association between active trachoma and
conjunctival pathogens, when compared to normal healthy
controls.16 Surprisingly, the authors reached the opposite con-
clusion—that individuals with trachomatous conjunctivitis
were no more likely to grow a pathogen than controls. How-
ever, in their analysis, they included within the control group
a large number of individuals with “simple bacterial conjunc-
tivitis,” which added to the number of pathogens identified in
the control group and probably should not have been regarded
as clinically normal.
We have previously found that individuals with established
trichiasis and conjunctival scarring are more likely to have
nonchlamydial bacterial infections.22–24 This is often associ-
ated with a marked clinically apparent inflammatory reaction
in the conjunctiva in the absence of detectable C. trachomatis
infection.22 In addition, after trichiasis surgery, individuals
with bacterial infection had significantly increased expression
of various factors that could plausibly be involved with the
scarring process (interleukin-1, tumor necrosis factor–, and
matrix metalloproteinases-1 and -9).25 This raises the possibility
that these other bacteria could contribute to stimulating progres-
sive cicatricial disease in conjunctiva that has previously been
damaged by the immune response to C. trachomatis.
This study, from an area with low prevalence trachoma,
indicates the potential importance of nonchlamydial bacterial
pathogens in the production of a follicular phenotype. The
possibility of reverse causality in the association between bac-
terial pathogens and follicular conjunctivitis (namely, that eyes
with TF are more susceptible to being infected with bacteria)
cannot be ruled out in a cross-sectional study. However, even
TABLE 5. Multivariable Logistic Regression Model for Trachomatous
Inflammation-Follicular
Variable OR 95% CI P*
Age group, y
0–3 1 — 0.25
4–6 0.80 0.42–1.52 —
7–10 0.66 0.33–1.35 —
Bacterial species
Streptococcus pneumoniae 3.22 1.56–6.66 0.003
Haemophilus influenzae, type B 2.92 1.47–5.81 0.003
Haemophilus influenzae, non-type B 5.34 2.57–11.3 0.001
* P values are derived by likelihood ratio testing. For age group, P
value is for trend.
TABLE 4. Univariate Associations with Trachomatous
Inflammation-Follicular
Variable OR 95% CI P*
Sex, female 1.33 0.79–2.26 0.28
Age group, y
0–3 1 — 0.06
4–6 0.68 0.37–1.25 —
7–10 0.46 0.23–0.90 —
Chlamydia trachomatis 1.21 0.40–3.64 0.74
Bacterial infection
None 1.00 — 0.001
Commensal only 1.54 0.68–3.53 —
Pathogen 4.68 2.31–9.50 —
Bacterial species
Viridans group streptococcus 1.08 0.62–1.88 0.78
Staphylococcus epidermidis 0.91 0.43–1.94 0.81
Corynebacterium spp. 0.77 0.29–2.02 0.58
Streptococcus pneumoniae 3.02 1.52–6.01 0.003
Haemophilus influenzae, type B 2.34 1.24–4.42 0.01
Haemophilus influenzae, non–type B 4.07 2.04–8.14 0.001
* P values are derived from likelihood ratio testing. For categorical
variables (age group and bacterial infection), overall P values are
shown.
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if this is part of the explanation for the observed association, it
remains probable that these other bacteria contribute to the
inflammatory response. It has long been recognized that vari-
ous viral and bacterial pathogens can cause a follicular con-
junctivitis. It is conceivable that these effects are amplified in a
trachoma-endemic population: individuals who have previ-
ously developed a follicular conjunctivitis in response to C.
trachomatis may more readily reform conjunctival follicles
when challenged with certain other bacterial species. This may
provide part of the explanation why the community preva-
lence of TF declines more slowly than chlamydial infection
after the successful introduction of MDA.8,9 A rapid, inexpen-
sive point of care (POC) test would potentially be very useful
to control programs, by providing an indication of whether C.
trachomatis is no longer endemic in the face of persisting TF,
allowing MDA to be stopped at an earlier stage.26 Unfortunately,
because there is not currently a POC test available, control pro-
grams have to base the decision of whether to continue treating
on the community prevalence of TF. There is probably some
potential to refine the treatment algorithm further as more em-
piric data on the relationship between infection and disease at
different prevalence levels becomes available.
TABLE 6. Studies of Conjunctival Bacterial Infection in Children in Trachoma Endemic Communities
Country (Year) Study Population and Design Findings Comments
Taiwan (1962)16 Three separate trachoma endemic
areas; conjunctival swab
samples from preschool and
first-grade children; about half
had active trachoma;
cultured (blood and chocolate
agar)
Culture positive; normal, 42/144 (29%);
active trachoma, 74/201 (37%);
organisms: Staphylococcus
pneumoniae, 15.6%; -streptococci,
11.6%; Haemophilus, 6.4%;
Staphylococcus spp., 5.0%
Sampling frame not specified, drawn
from a number of different
settings; variation of MacCallan’s
trachoma grading system used,
making it difficult to relate to
current clinical grades (to derive
an approximation to active
trachoma, Tr-D, Tr-I Tr-II, Tr-III,
and CFC have been combined
here); no Chlamydia trachomatis
test data presented; reanalysis of
the data suggests a significant
association between active
trachoma and bacterial
infection (OR, 2.58; 95% CI, 1.6–
4.0; P  0.0010)
USA (1967)17 School children (140) enrolled in
a treatment trial for active
trachoma; cultured (blood
agar); microbiology results
from before and after treatment
combined
Culture positive; normal/Tr-4, 41%, and
Tr-I, Tr-II, and Tr-III, 43%
Sampling frame not specified;
MacCallan’s trachoma grading
system used; microbiology results
from before and after treatment
combined; no C. trachomatis test
data presented.
Morocco (1968)18 Sample from 16 communities
enrolled in a trachoma control
study; in each community,
160–180 children 0–8 years of
age were randomly selected;
conjunctival scrapings were
Gram stained; no culture
Positive slide: Haemophilus, 81%;
Moraxella, 20%; S. pneumoniae, 19%
MacCallan’s trachoma grading
system used; denominator not
stated; no C. trachomatis test data
presented; no analysis of bacterial
infection in relation to active
trachoma
Tunisia (1974)19 Two villages—(A) 151 children
6–9 years with active
trachoma; (B) 44 children 15
years, randomly selected;
conjunctival swab (cultured
blood agar); conjunctival
smear, Giemsa stain for
chlamydial inclusions
Culture positive: S. viridans, 65%;
Diphtheroids, 52%; Haemophilus
spp., 40%; S. epidermidis, 13%
The number of children
contributing data to the reported
culture results was 277, and this
is higher than the 195 children
described in the subject
description; the age and clinical
status of the additional 82
children is not presented;
Haemophilus was found to be the
major cause of mucopurulent
conjunctivitis; no analysis of
bacterial infection in relation to
active trachoma
Tunisia (1975)20 Single village—151 children
initially having active trachoma
were enrolled into a treatment
trial; conjunctival scraping with
Giemsa staining; no culture;
each child had both eyes
sampled on three occasions
Results of 927 slides presented; slides
positive for bacteria: 48%
(Haemophilus, 25% and Moraxella,
16%)
Difficult to interpret, because
multiple data from both eyes are
presented together; no analysis of
bacterial infection in relation to
active trachoma
Nepal (1999)21 Single village—122 children 1–10
years of age; conjunctival
swab (cultured blood agar)
Active trachoma in 38%; S.
pneumoniae, 22%; Haemophilus
spp., 7%; Moraxella, 16%
The focus of this study was the
change in bacterial antibiotic
sensitivity patterns after
azithromycin treatment; no C.
trachomatis test data presented;
no analysis of bacterial infection
in relation to active trachoma
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